Alberto Garrone Selected Research

Acute Myeloid Leukemia (Acute Myelogenous Leukemia)

11/2004

Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alberto Garrone Research Topics

Disease

1	Pneumonia (Pneumonitis) 01/2021
1	COVID-19 01/2021
1	Critical Illness (Critically Ill) 01/2021
1	Chronic Limb-Threatening Ischemia 07/2012
1	Hodgkin Disease (Hodgkin's Disease) 10/2005
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2005
1	Multiple Myeloma 10/2005
1	Neoplasms (Cancer) 10/2005
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2004
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2004
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2004
1	Leukemia 11/2004

Drug/Important Bio-Agent (IBA)

2	Daunorubicin (Cerubidine)FDA LinkGeneric 12/2004 - 11/2004
2	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2004 - 11/2004
2	fludarabineIBA 12/2004 - 11/2004
1	Oxygen (Dioxygen)IBA 01/2021
1	AnticoagulantsIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Mitoxantrone (Novantrone)FDA LinkGeneric 10/2005
1	Etoposide (VP 16)FDA LinkGeneric 10/2005
1	Ifosfamide FDA LinkGeneric 10/2005
1	Melphalan (Alkeran)FDA LinkGeneric 10/2005
1	Epirubicin (Ellence)FDA LinkGeneric 10/2005

Therapy/Procedure

2	Therapeutics 01/2021 - 11/2004
2	Salvage Therapy 10/2005 - 12/2004
1	Hemoperfusion 01/2021
1	Continuous Positive Airway Pressure 01/2021
1	Autologous Transplantation 07/2012